戻る Agenda
Day 2: Session 6:
Session Chair(s)
Rajinder Jalali
VP & Head,Medical Affairs & Clinical Research and Global Head Pharmacovigilance
Sun Pharma, India
Speaker(s)
Day 2: Session 6.1: Machine Learning & Artificial I telligence in PV – A Case Study
Jayathirtha Gopalakrishna
Oracle Inc, United States
Principal Sales Consultant, Health Sciences Global Business Unit
Day 2: Session 6.2: New Approaches to Risk Management & Risk Minimization – Global Strategies
David John Lewis, PhD
Novartis Pharma Gmbh, Switzerland
Former Head QPPV PRRC Office, Patient Safety & Pharmacovigilance
Day 2: Session 6.2: New Approaches to Risk Management & Risk Minimization – Global Strategies
Sibin Kurian
Novartis Pharma AG,, Switzerland
Therapeutic Area Safety Lead